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Abstract
Background: The intensity of the inflammation induced by Helicobacter pylori colonization is
associated with the development of distal gastric cancer (GC). The host response to H. pylori has
been related to genetic polymorphisms that influence both innate and adaptive immune responses.
Our aim was to investigate whether the presence of the TLR4 Asp299Gly, TLR4 Thr399Ile and IL-8-
251 A/T polymorphisms had any influence in the development of distal GC in a Mexican population.
Methods: We studied 337 patients that were divided in two groups: 78 patients with histologically
confirmed distal GC and 259 non-cancer controls. The presence of H. pylori in the control
population was defined by positive results of at least two of four diagnostic tests: serology,
histology, rapid urease test and culture. Human DNA was purified and genotyped for TLR4
Asp299Gly polymorphism by pyrosequencing, for TLR4 Thr399Ile by PCR-RFLP and for IL8-251 by
the amplification refractory mutation system (ARMS)-PCR.
Results: The non-cancer control group was found to be in Hardy-Weinberg equilibrium at the
polymorphic loci studied (chi-square H-W = 0.58 for IL8-251, 0.42 for TLR4 Asp299Gly and 0.17 for
TLR4 Thr399Ile). The frequencies of mutated alleles (homozygous plus heterozygous) were
compared between cases and controls. We found no significant difference for TLR4- Asp299Gly [the
7.7% of distal GC patients and 7.7 % non-cancer controls (p = 0.82)] and for TLR4 Thr399Ile [the
1.3% of GC patients and the 5% of the control population (p = 0.2)]. In contrast, for IL-8-251 A/T,
80.77% of the GC patients and 66.4% in the control group age and gender matched had at least one
copy of mutated allele (OR = 2.12, 95% CI = 1.1–4.2) (p = 0.023).
Conclusion: This study showed that the IL8-251*A allele could be related to the development of
distal gastric cancer in this Mexican population.
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Background
Helicobacter pylori almost exclusively colonize the mucous
layer of the human stomach and reside in the host for
years, decades or maybe lifelong. In approximately 10%
of cases, the organism is associated with diverse clinical
outcomes, including non-ulcer dyspepsia, peptic ulcer
disease, and distal gastric cancer [1].
Both host and environmental factors have been associated
with this clinical diversity. Host factors are mainly related
to the recognition of the bacteria by the immune system
and variation in the level of cytokine response [2,3].
Recognition of pathogens is mediated by a set of germ-
line-encoded receptors that are referred to as pattern-rec-
ognition receptors (PRRs). These receptors recognize
conserved molecular patterns, which are shared by large
groups of microorganisms. An important PRR is Toll-like
receptor 4 (TLR4), a transmembrane receptor that recog-
nizes a range of ligands, including lipopolysaccharide
(LPS), which is found in the cell wall of Gram-negative
bacteria like H. pylori [3]. Two single nucleotide polymor-
phisms (SNPs) in the TLR4 gene, Asp-299→Gly and Thr-
399→Ile transitions, have been shown to lead to hypore-
sponsiveness to LPS, reduced epithelial TLR4 density and
reduced inflammatory cytokine response to LPS [4]. Fur-
thermore, genetic variants of cytokines are also critical for
the inflammatory response, and several genes from differ-
ent pathways have been associated with gastric cancer,
including interleukin (IL)-1B, TNF, IL-10 and IL-8 [5-7].
IL-8 cytokine functions as a potent chemoattractant for
neutrophils and lymphocytes. It has been reported that IL-
8 levels increased 10-fold in gastric cancer specimens
when compared with normal gastric tissues. A well-char-
acterized SNP T/A in the -251 locus has been described
and associated with higher IL-8 production and several
diseases [8-11].
Our aim was to determine whether the TLR4 Asp299Gly,
TLR4 Thr399Ile and the IL8-251 A/T polymorphisms are
associated with distal gastric cancer in a well-defined Mex-
ican population.
Methods
Patient population
We studied 78 unrelated patients with histologically con-
firmed distal GC (mean age = 58.6y, median age = 60, age
range: 22–84, F:M = 0.56). We also studied 259 patients
with no histological evidence of GC (mean age = 57.1y,
median age = 54, age range = 18–92, F:M = 1.17). This
population has been described previously [7]. All patients
were enrolled at the Hospital Universitario "Dr. José Eleu-
terio González", Universidad Autónoma de Nuevo León.
The local ethical committee approved the study and writ-
ten informed consent was obtained from all subjects.
Histopathological examinations
From all control patients, eight biopsy specimens were
obtained for histological evaluation, two from the lesser
curvature, two from the greater curvature, two from the
incisura angularis, and two from the prepyloric region.
From patients with distal GC, at least 8 biopsies were
obtained from the tumor for histological evaluation.
Biopsies from cases and controls were fixed, paraffin
embedded and stained with hematoxilin-eosin. An expe-
rienced pathologist examined all the histological slides.
H. pylori status
The H. pylori status of the control population was deter-
mined by histology, the rapid urease test (RUT), serology
and culture. For the RUT, an antral biopsy was analyzed
by a validated non-commercial test [12]. The biopsy was
placed in a test vial, incubated at 37°C and read within 24
h. A color change from orange to magenta indicated a pos-
itive result. For serology, an enzyme-linked immunosorb-
ent assay (ELISA) was used to demonstrate the presence of
IgG antibodies as previously described [13].
Culture was performed on two corpus and two antrum
biopsies by standard methods. Biopsies were placed in
10% blood agar (Becton Dickinson, Cockeysville, MD)
and incubated at 37°C for at least one week under micro-
aerobic conditions. Strains were identified by Gram stain-
ing, oxidase, catalase and urease tests.
Control patients were considered H. pylori infected when
at least two of the diagnostic tests were positive.
The prevalence of H. pylori infection in gastric cancer
patients was determined by the result of histology only.
Genotyping
Genomic DNA was extracted from peripheral blood by
the phenol-chloroform-isoamilic alcohol and precipita-
tion with ethanol method. An amplification refractory
mutation system (ARMS)-PCR method was used to geno-
type the IL8-251 polymorphism as described previously
[14].
The TLR4 Thr399Ile polymorphism was determined by
PCR-RFLP [15] and the TLR4 Asp299Gly polymorphism
was determined by a pyrosequencing method designed
for this study. Initially, a PCR was performed with the
primers F-GAT TAG CAT ACT TAG ACT ACT ACC TCC
ATG and R-CCC TTT CAA TAG TCA CAC TCA CCA GG
with the reverse primer biotinylated. The PCR conditions
were: 94°C for 5 min and 40 cycles of 94°C, 59°C and
72°C for 30 s each, and a final extension at 72°C for 5BMC Cancer 2007, 7:70 http://www.biomedcentral.com/1471-2407/7/70
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min. For pyrosequencing, biotinylated PCR templates
were immobilized on streptavidin-coated paramagnetic
Sepahrose beads in binding buffer. The bead-template
complexes were washed by submersion in 70% alcohol
and 0.5 M NaOH and then added to 45 µl of annealing
buffer containing 15 pmol of the sequencing primer 5'-
CAT ACT TAG ACT ACT ACC TC 3'. Annealing took place
at 80°C for 2 min. Real-time pyrosequencing was per-
formed in an automated 96-well pyrosequencer PSQ SNP
96 (Pyrosequencing AB, Uppsala, Sweden) using enzymes
and substrates recommended by the manufacturer.
Statistical analysis
Hardy-Weinberg equilibrium of alleles at individual loci
was assessed by chi-square statistics. Statistically signifi-
cant differences were determined by Student's t test, chi-
square or Fisher exact test, two tailed. A probability (p)
value < 0.05 was considered as statistically significant.
Odds ratios (OR) with 95% confidence intervals (CIs)
were computed using the Epi-Info 2000 software (Center
for Disease Control and Prevention, Atlanta, Ga.). Three
analyses were performed, one in which all cases and con-
trols were included, a second in which cases were com-
pared only with H. pylori + controls and a third analysis in
which the population-based controls were matched by 5-
year age group and gender with the cancer cases.
Results
Study groups characteristics and H. pylori status
The distribution of genotypes according to histological
findings is shown on Table 1.
The genotype frequencies at the individual loci studied
were in Hardy-Weinberg equilibrium, with non-signifi-
cant chi-square values (0.58 for IL8-251, 0.42 for TLR4
Asp299Gly and 0.17 for the TLR4 Thr399Ile). Among the
control group, the 80% had chronic gastritis (Table 1),
11.2% of patients had PUD and 8.8% of patients had
atrophic gastritis and/or intestinal metaplasia. The pro-
portion of diffuse and intestinal gastric cancer was 1.2:1.
The prevalence of H. pylori in the control group was
73.7%. This is similar to the value previously reported for
this study population [16]. The prevalence of H. pylori
among the gastric cancer patients was 53.8%.
Assessment of risk of IL8-251 A/T, TLR4 Asp299Gly and 
TLR4 Thr399Ile genotypes
We compared all particular genotypes for IL8-251 (AA, AT
and TT), for TLR4 Asp299Gly (1,1, 1,2 and 2,2) and TLR4
Thr399Ile (1,1, 1,2 and 2,2) (Table 1). The frequency of
the IL8-251 AT genotype was higher in the gastric cancer
cases than in all controls, only H. pylori positive controls
and age and gender matched controls (Table 2).
Assessment of risk of IL8-251*A, TLR4 Asp299Gly*2 and 
TLR4 Thr399Ile*2 alleles
We next compared the carriage of the IL8-251*A allele
(homozygous plus heterozygous) for GC cases and all gas-
tritis plus normal controls. We found an association of the
IL8-251 *A allele and the development of GC (OR = 2.12,
95% CI = 1.1–4.2, p = 0.023) (Table 2). When we com-
pared all gastritis plus normal controls vs histological can-
cer types, the risks for diffuse and intestinal gastric cancer
types were similar but not significant (OR = 2.15, p = 0.08
and OR = 2.1, p = 0.13 respectively).
When we compared the gastric cancer cases with the H.
pylori+ controls we found a similar value (OR = 2.12, 95%
CI = 1.1–4.2, p = 0.029).
Next, we compared the frequency in the gastric cancer
group withage and gender matched controls and we
found a stronger association (OR: 2.42, 95% CI = 1.2–4.8,
p = 0.0.009).
We did not find any association for TLR4 Asp299Gly*2
and TLR4 Thr399Ile*2 hyporeactive alleles.
Discussions and conclusion
The diversity in response to the infection by H. pylori has
been attributed to several factors. The genetically regu-
lated immune response seems to play a crucial role in
determining the intensity of damage to the host [1-3].
Several authors have described the increased production
of IL-8 during H. pylori infection. An A/T polymorphism at
the position -251 in the gene has been associated to a
higher activity of this interleukin and recently, this allele
has been related in two studies to the development of gas-
tric cancer in Japanese population [10,11]. In one of those
studies, the IL8-251 AA genotype held a higher risk of
atrophic gastritis (OR = 2.35; 95%, CI = 1.12–4.94) and
gastric cancer (OR = 2.22; 95% CI = 1.08–4.56) compared
with the TT genotype. They studied 252 healthy controls,
215 individuals with atrophic gastritis, and 396 patients
with gastric cancer. The AA and AT genotypes were signif-
icantly associated with higher levels of IL8 protein, more
severe neutrophil infiltration compared with the TT geno-
type. In the other study, the IL-8 -251*A allele was associ-
ated to a higher risk of gastric cancer (OR = 2.1, 95% CI =
1.38–2.92). Our results showed no association between
higher rates of GC and the AA genotype, but a positive
association was found for the AT genotype and the car-
riage of at least one copy of the *A allele (homozygous
plus heterozygous). It is remarkable that the ORs value
observed in our study (2.12) was quite similar to that
observed in the Japanese population (2.1).BMC Cancer 2007, 7:70 http://www.biomedcentral.com/1471-2407/7/70
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The IL-1B-31 C/T polymorphism has been associated with
the development of gastric cancer and a geographical-eth-
nic difference has been described for this locus, with a
stronger association of the polymorphism in occidental
than in oriental population. The results for the IL-8-251 A/
T polymorphism correlate with previous data presented
for Japanese population, showing no trend in geographi-
cal or ethnic variation.
It is currently unresolved whether a hyporesponsive LPS
signaling pathway is beneficial or detrimental to the host.
Individuals with the hyporeactive TLR4 polymorphisms
have shown reduced levels of circulating inflammatory
cytokines, an increased risk of acute bacterial infections
and a trend towards increased mortality. Other recent
studies support the hypothesis that the low-functioning
TLR4 polymorphisms may result in a reduced inflamma-
tory response associated with a low-damaging infection
that will promote a persistent infection [17-20]. In this
study, we did not find any association between GC and
TLR4 polymorphisms, suggesting they do not contribute
to the development of distal gastric cancer. Both TLR4
Asp299Gly  and  Thr399Ile  polymorphisms have been
reported in linkage disequilibrium (LD) [21,22], but we
decided to genotype both because we did not know if they
were in LD in our population.
In conclusion, our preliminary results suggest that IL8-251
is a biologically plausible disease-modifying polymor-
phism. If confirmed in multiple populations, as it has
been in Japanese, and now Mexican groups, this polymor-
phic site, in conjunction with others, could be used to
identify patients at greater risk for GC, who may need
closer monitoring.
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Table 1: Genotype and allele frequencies of the IL-8 251 A/T and TLR-299 and -399 loci in the non-cancer and cancer groups according 
to histological findings
IL8-251 A/T TLR4 Asp299Gly TLR4Thr399Ile
Group (n) genotype allele genotype allele genotype allele
AA AT TT *A *T 1,1 1,2 *1 *2 1,1 1,2 *1 *2
Gastritis (207) 42 97 68 0.44 0.56 190 17 0.96 0.04 196 11 0.97 0.03
PUD (29) 4 14 11 0.38 0.62 29 0 1 0 27 2 0.97 0.03
AG + IM (23) 5 10 8 0.43 0.57 20 3 0.93 0.07 23 0 1 0
Gastric cancer (78) 16 47 15 0.51 0.49 72 6 0.96 0.04 77 1 0.99 0.01
diffuse type 8 26 8 0.5 0.5 38 4 0.95 0.05 41 1 0.99 0.01
intestinal type 8 21 7 0.51 0.49 34 2 0.97 0.03 36 0 1 0
H. pylori + (191) 37 90 64 0.43 0.57 175 16 0.96 0.04 181 10 0.97 0.03
Age and gender matched (n = 189) 33 87 69 0.4 0.6 175 14 0.96 0.04 179 10 0.97 0.03
PUD: peptic ulcer disease; AG, atrophic gastritis; IM: intestinal metaplasia
Table 2: Odds ratios and 95% confidence intervals for the analysis the genotypes of distal gastric cancer cases vs all non-cancer 
controls.
IL8-251*A IL8-251 AT TLR-299*2 TLR-399*2
All cases vs OR (95% CI) p OR (95% CI) p OR 95% CI p OR 95% CI p
All controls (n = 259) 2.12 (1.1–4.2) 0.023 1.73 (1–3) 0.049 1 (0.3–2.8) .82 0.25 (0.01–1.8) 0.2
H. pylori + controls (n = 191) 2.12 (1.1–4.2) 0.029 1.7 (0.96–3) 0.068 0.91 (0.3–2.6) 0.95 0.24 (0–1.8) 0.19
Age and gender matched controls (n = 189) 2.42 (1.2–4.8) 0.009 1.78 (1–3.2 0.035 1.04 (0.3–3.1) 0.86 0.23 (0–1.8) 0.1Publish with BioMed Central    and   every 
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